Of all the possible side effects that come with taking a GLP-1, losing your hair is perhaps one of the scariest. The good ...

WeDosify becomes CLM’s first commercially available product – delivering data-driven, adaptive dosing recommendations to improve GLP-1 adherence.Informed by 29 studies and 15,000+ patient profiles; ...

Great. Thanks for joining us, everyone. I'm Terence Flynn, the U.S. biopharma analyst here at Morgan Stanley. I'm very pleased to be hosting Structure Therapeutics. Joining us today from the company, ...

Earlier in 2025, UNSW Sydney Ph.D. candidate Christina Schmidt submitted her thesis—from the deck of Australia's ...

Working together as a team to better communicate between physicians and nurses as well as the complete caregiving team will ...

A shortage of laboratories, equipment and chemicals continues to undermine student performance in science subjects across the country ...

Get going with our next company presenter at the BofA Healthcare Conference here in London. Pleased to be introducing Teva Pharmaceuticals and CEO, Richard Francis. My name is Jason Gerberry. I'm one ...

A cannabis extract appears to provide sustained relief from chronic low back pain without signs of addiction or withdrawal, ...

VIENNA — Tirzepatide was associated with improvements in body weight and body composition, and with lower insulin doses, in the first-ever randomized controlled trial (RCT) of the drug in people with ...

This study is reported by the team of Professor Shuang-jiang Liu from Shandong University. The study reveals that the gut probiotic Christensenella ...

By seeing yourself with grace, you create an internal safe space where you can grow. You can love your shadow and feel unconditional love, When you have your own back, you’ll feel braver to take the ...

From unique wildlife to resilient microbes, world-changing climate dynamics to untapped biotechnological potential – four UNSW scientists ...